In a report released on March 16, Siddharth Rajeev from Fundamental Research initiated coverage with a Buy rating on Ocean Biomedical (OCEA – Research Report) and a price target of $16.40. The company’s shares closed last Friday at $7.17.
According to TipRanks, Rajeev is an analyst with an average return of -2.3% and a 33.06% success rate.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ocean Biomedical with a $13.20 average price target, which is an 84.10% upside from current levels. In a report released on March 13, EF Hutton also initiated coverage with a Buy rating on the stock with a $10.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $26.60 and a one-year low of $3.06. Currently, Ocean Biomedical has an average volume of 2.57M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Read More on OCEA:
- Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a “Buy” Recommendation
- Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a “Buy” Recommendation
- Ocean Biomedical initiated with a Buy at EF Hutton
- Ocean Biomedical More than Doubles after Presenting Research Data
- Ocean Biomedical shares research data on anti-tumor pathway discoveries
